Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893646688> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2893646688 endingPage "905" @default.
- W2893646688 startingPage "899" @default.
- W2893646688 abstract "Analytic, pharmacokinetic (PK), and clinical similarity between the biosimilar ABP 215 and bevacizumab has previously been demonstrated in global studies. Here we present a phase 1 study in healthy adult Japanese men. This study was a randomized, single-blind, single-dose, parallel-group study comparing PK parameters of ABP 215 versus EU-authorized bevacizumab in healthy Japanese men. Primary endpoints were maximum observed serum concentration (Cmax) and area under the serum concentration—time curve from time 0 to infinity (AUCinf). Secondary endpoints included AUC from time 0 to time of last quantifiable concentration (AUClast), safety, tolerability, and immunogenicity. Baseline characteristics were similar among study subjects (n = 24/group). After a 3-mg/kg intravenous infusion, the geometric means (GMs) of Cmax, AUCinf, and AUClast were 71.2 µg/mL, 25,259 µg h/mL, and 22,499.3 µg h/mL, respectively, for ABP 215 and 70.16 µg/mL, 25,801 µg h/mL, and 22,604.6 µg h/mL, respectively, for bevacizumab. The GM ratios (90% confidence interval; CI) for Cmax, AUCinf, and AUClast were 1.015 (0.946–1.088), 0.979 (0.914–1.049), and 0.995 (0.941–1.053) for ABP 215 versus bevacizumab. All CIs fell within the prespecified bioequivalence margin (0.80–1.25). Adverse events (AEs) occurred in 2/24 subjects receiving ABP 215 and 1/24 receiving bevacizumab. There were no deaths or AEs leading to study discontinuation; no subject was positive for binding anti-drug antibodies (ADAs). ABP 215 and bevacizumab showed PK similarity in Japanese men. Safety profiles were comparable between the two groups. The pharmacokinetics in Japanese subjects were consistent with those in a previous global PK equivalence study." @default.
- W2893646688 created "2018-10-05" @default.
- W2893646688 creator A5014416915 @default.
- W2893646688 creator A5027398005 @default.
- W2893646688 creator A5051124193 @default.
- W2893646688 creator A5078398114 @default.
- W2893646688 date "2018-09-29" @default.
- W2893646688 modified "2023-10-18" @default.
- W2893646688 title "A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects" @default.
- W2893646688 cites W2032921998 @default.
- W2893646688 cites W2296444677 @default.
- W2893646688 cites W2752880203 @default.
- W2893646688 cites W2794416238 @default.
- W2893646688 doi "https://doi.org/10.1007/s00280-018-3695-4" @default.
- W2893646688 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6182752" @default.
- W2893646688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30269275" @default.
- W2893646688 hasPublicationYear "2018" @default.
- W2893646688 type Work @default.
- W2893646688 sameAs 2893646688 @default.
- W2893646688 citedByCount "14" @default.
- W2893646688 countsByYear W28936466882019 @default.
- W2893646688 countsByYear W28936466882020 @default.
- W2893646688 countsByYear W28936466882021 @default.
- W2893646688 countsByYear W28936466882022 @default.
- W2893646688 countsByYear W28936466882023 @default.
- W2893646688 crossrefType "journal-article" @default.
- W2893646688 hasAuthorship W2893646688A5014416915 @default.
- W2893646688 hasAuthorship W2893646688A5027398005 @default.
- W2893646688 hasAuthorship W2893646688A5051124193 @default.
- W2893646688 hasAuthorship W2893646688A5078398114 @default.
- W2893646688 hasBestOaLocation W28936466881 @default.
- W2893646688 hasConcept C112705442 @default.
- W2893646688 hasConcept C126322002 @default.
- W2893646688 hasConcept C197934379 @default.
- W2893646688 hasConcept C22979827 @default.
- W2893646688 hasConcept C2776694085 @default.
- W2893646688 hasConcept C2777802072 @default.
- W2893646688 hasConcept C2778375690 @default.
- W2893646688 hasConcept C2778715236 @default.
- W2893646688 hasConcept C42404028 @default.
- W2893646688 hasConcept C44249647 @default.
- W2893646688 hasConcept C71924100 @default.
- W2893646688 hasConcept C90924648 @default.
- W2893646688 hasConcept C98274493 @default.
- W2893646688 hasConceptScore W2893646688C112705442 @default.
- W2893646688 hasConceptScore W2893646688C126322002 @default.
- W2893646688 hasConceptScore W2893646688C197934379 @default.
- W2893646688 hasConceptScore W2893646688C22979827 @default.
- W2893646688 hasConceptScore W2893646688C2776694085 @default.
- W2893646688 hasConceptScore W2893646688C2777802072 @default.
- W2893646688 hasConceptScore W2893646688C2778375690 @default.
- W2893646688 hasConceptScore W2893646688C2778715236 @default.
- W2893646688 hasConceptScore W2893646688C42404028 @default.
- W2893646688 hasConceptScore W2893646688C44249647 @default.
- W2893646688 hasConceptScore W2893646688C71924100 @default.
- W2893646688 hasConceptScore W2893646688C90924648 @default.
- W2893646688 hasConceptScore W2893646688C98274493 @default.
- W2893646688 hasFunder F4320307105 @default.
- W2893646688 hasIssue "5" @default.
- W2893646688 hasLocation W28936466881 @default.
- W2893646688 hasLocation W28936466882 @default.
- W2893646688 hasLocation W28936466883 @default.
- W2893646688 hasLocation W28936466884 @default.
- W2893646688 hasOpenAccess W2893646688 @default.
- W2893646688 hasPrimaryLocation W28936466881 @default.
- W2893646688 hasRelatedWork W2008610508 @default.
- W2893646688 hasRelatedWork W2127903072 @default.
- W2893646688 hasRelatedWork W2131666897 @default.
- W2893646688 hasRelatedWork W2777540367 @default.
- W2893646688 hasRelatedWork W2792233399 @default.
- W2893646688 hasRelatedWork W2914758292 @default.
- W2893646688 hasRelatedWork W3089081291 @default.
- W2893646688 hasRelatedWork W3145656073 @default.
- W2893646688 hasRelatedWork W4212968951 @default.
- W2893646688 hasRelatedWork W4321478834 @default.
- W2893646688 hasVolume "82" @default.
- W2893646688 isParatext "false" @default.
- W2893646688 isRetracted "false" @default.
- W2893646688 magId "2893646688" @default.
- W2893646688 workType "article" @default.